Breaking News Instant updates and real-time market news.

PG

Procter & Gamble

$89.66

0.28 (0.31%)

, JPM

JPMorgan

$86.18

-0.39 (-0.45%)

18:40
06/18/17
06/18
18:40
06/18/17
18:40

Procter & Gamble, JPMorgan yet to return to YouTube, WSJ says

As part of a larger article on issues surrounding programmatic ad buying, the Wall Street Journal reports that SC Johnson, Procter & Gamble (PG) and JPMorgan (JPM) are among companies yet to return to Alphabet's (GOOG) YouTube after its recent ad placement controversy, according to sources. JPMorgan is working with the company to get its ads back on "safe" YouTube channels and expects to return shortly, one of the sources told the Journal. Recurring placement issues have led some brands to adjust their approach to ad buying, with Colgate-Palmolive (CL) requiring its ad firm to maintain a "blacklist" of sites it doesn't want to be affiliated with, sources told the publication. Reference Link

PG

Procter & Gamble

$89.66

0.28 (0.31%)

JPM

JPMorgan

$86.18

-0.39 (-0.45%)

GOOG

Alphabet

$939.78

-2.53 (-0.27%)

GOOGL

Alphabet Class A

$958.62

-1.56 (-0.16%)

CL

Colgate-Palmolive

$76.31

-0.04 (-0.05%)

  • 28

    Jun

  • 14

    Jul

  • 19

    Jul

  • 12

    Oct

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

PG Procter & Gamble
$89.66

0.28 (0.31%)

03/06/17
RILY
03/06/17
DOWNGRADE
Target $91
RILY
Neutral
Procter & Gamble downgraded to Neutral from Buy at B. Riley
B. Riley analyst Linda Bolton Weiser downgraded Procter & Gamble to Neutral saying that while the stock is up 11% from the December low, the company's fundamentals have weakened. The analyst cut her price target for the shares to $91 from $106.
03/06/17
03/06/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. MetLife (MET) downgraded to Neutral from Buy at BofA/Merrill with analyst Seth Weiss saying shares are now trading above the level of the disappointing fourth quarter earnings report and prefers Prudential (PRU) given it benefits more from improving interest rates and easing regulations. 2. Procter & Gamble (PG) downgraded to Neutral from Buy at B. Riley with analyst Linda Bolton Weiser saying that while the stock is up 11% from the December low, the company's fundamentals have weakened. The analyst cut her price target for the shares to $91 from $106. 3. GoPro (GPRO) downgraded to Sell from Neutral at Goldman with analyst Simona Jankowski saying the company faces "significant challenges" amid camera market saturation, product rollout issues in the holiday season, and a disappointing entry into the drone market. The analyst sees risk to consensus estimates and views the stock as overvalued. 4. Hawaiian Electric (HE) downgraded to Underperform from In Line at Evercore ISI with analyst Greg Gordon saying he believes the risk/return for shares is skewed to the downside and estimates a "significantly lower total return" compared to other utilities he covers. He maintains a $31 price target on Hawaiian Electric shares. 5. Akorn (AKRX) downgraded to Hold from Buy at Deutsche Bank with analyst Gregg Gilbert saying the risk/reward is more balanced following the recent rally in the shares. Upside from current levels will have more to do with the "hard-to-call dynamics of new product approvals vs. base business erosion," Gilbert tells investors in a research note. He cut his price target for the shares to $24 from $28. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/21/17
JPMS
03/21/17
INITIATION
Target $98
JPMS
Neutral
Procter & Gamble initiated with a Neutral at JPMorgan
JPMorgan analyst Andrea Teixeira started Procter & Gamble with a Neutral rating and $98 price target.
05/04/17
SUSQ
05/04/17
NO CHANGE
Target $41
SUSQ
Positive
Trade Desk wins Procter & Gamble as a customer, says Susquehanna
As reported by AdvertisingAge today, Procter & Gamble (PG) is moving its DSP business to Trade Desk's (TTD) platform in North America, as well as other geographies. Susquehanna analyst Shyam Patil said the win broadens Trade Desk's base of Tier 1 advertising partners and validates the company's market leadership and its ability to rapidly gain programmatic share. The analyst rates Trade Desk a Positive with a $41 price target.
JPM JPMorgan
$86.18

-0.39 (-0.45%)

06/09/17
RBCM
06/09/17
NO CHANGE
RBCM
House financial reform bill unlikely to advance in Senate, says RBC Capital
RBC Capital analyst Gerard Cassidy says that the financial regulation reform bill passed yesterday by the House would help the banking sector but probably won;t be passed by the Senate. Large publicly traded banks include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC).
04/25/17
04/25/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Best Buy (BBY) upgraded to Buy from Neutral at BofA/Merrill with analyst Denise Chai citing stronger than expected product cycles in TVs, phones, and time smart home technology, strong online growth, increased focus on high margin services like subscription warranties and in-home services, and new cost savings opportunities. 2. JPMorgan (JPM) and American Express (AXP) were upgraded to Buy from Neutral at Guggenheim while Wells Fargo (WFC) was upgraded to Neutral from Sell. 3. Crane (CR) upgraded to Outperform from Market Perform at William Blair with analyst Nicholas Heymann citing the company's first quarter results. 4. NCI Building (NCS) upgraded to Outperform from Sector Perform at RBC Capital with analyst Robert Wetenhall saying he is more confident in the outlook of the company's end markets and the growth potential of its insulated metal panels business. The analyst believes that worries about the impact of steel price fluctuations on the company's margins are overdone, as he says that hedging can reduce the impact of such fluctuations. 5. Terex (TEX) upgraded to Overweight from Neutral at JPMorgan with analyst Ann Duignan saying the stock looks undervalued based on the company's 2020 targets. Following Terex's Q1 upside and raised 2017 outlook, the analyst upped her price target for the shares to $47 from $30. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/25/17
GUGG
04/25/17
UPGRADE
Target $96
GUGG
Buy
JPMorgan upgraded to Buy on earnings momentum at Guggenheim
As previously reported, Guggenheim upgraded JPMorgan to Buy from Neutral with a $96 price target. Analyst Eric Wasserstrom said fundamental trends have been stronger than forecasts and believes there is upside potential in the core loan forecast of 6% in 2017, indicating sustained earnings momentum even in a period without improving macro conditions.
04/25/17
GUGG
04/25/17
UPGRADE
GUGG
Buy
JPMorgan upgraded to Buy from Neutral at Guggenheim
GOOG Alphabet
$939.78

-2.53 (-0.27%)

06/15/17
06/15/17
NO CHANGE

FANG fundamentals still strong but stocks may moderate, says Canaccord
Canaccord analyst Michael Graham noted the FANG stocks - Facebook (FB),Amazon (AMZN), Netflix (NFLX), and Google parent Alphabet (GOOG) - outpaced the S&P by a great deal and he feels even though fundamentals remain strong, the shares' momentum may begin to moderate. Graham believes most of the growth opportunities in tech remain with the FANG group but he believes valuations are quite reasonable. He downgraded Alphabet to Hold from Buy and believes that Amazon is the one to own long-term.
06/15/17
ADAM
06/15/17
DOWNGRADE
Target $1000
ADAM
Hold
Alphabet downgraded to Hold on valuation at Canaccord
As previously reported, Canaccord analyst Michael Graham downgraded Alphabet to Hold from Buy citing valuation. The analyst still believe growth opportunities exist but the valuation is inline and he believes investors should take a step back. Graham maintained his $1,000 price target on Alphabet shares.
06/14/17
UBSW
06/14/17
NO CHANGE
Target $32
UBSW
Buy
Mindbody focus on high value subscribers the right strategy, says UBS
UBS analyst Ian Strgar said MindBody (MB) is now focused on high value subscribers, which he believes is the right strategy and should lead to a higher long-term average monthly revenue per subscriber, leading to a reacceleration of earnings and revenues. The analyst also sees the potential for an acquisition helping the strategy. He adds that its partnership with Google (GOOG) remains in its early innings and helps on the road to $1B in revenues. Strgar reiterated his Buy rating and raised his price target to $32 from $30 on MindBody shares.
06/15/17
06/15/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) downgraded to Hold from Buy at Canaccord with analyst Michael Graham citing valuation. Graham maintained his $1,000 price target on Alphabet shares. 2. Mattel (MAT) downgraded to Neutral from Buy at DA Davidson with analyst Linda Bolton saying near-term business fundamentals have deteriorated after the company cut its dividend by 61%. 3. Brinker (EAT) downgraded to Neutral from Overweight at JPMorgan with analyst John Ivankoe saying he expects higher spending and weak industry trends to offset any possible sales improvement. 4. Terex (TEX) downgraded to Neutral from Buy at Goldman Sachs with analyst Jerry Revinch citing valuation. 5. Splunk (SPLK) downgraded to Neutral from Outperform at Wedbush analyst Steve Koenig citing the emergence of "meaningful competition," the "complexity" of its transition to the cloud, and "somewhat messy fundamentals." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GOOGL Alphabet Class A
$958.62

-1.56 (-0.16%)

06/15/17
ADAM
06/15/17
DOWNGRADE
ADAM
Hold
Alphabet downgraded to Hold from Buy at Canaccord
CL Colgate-Palmolive
$76.31

-0.04 (-0.05%)

03/21/17
JPMS
03/21/17
INITIATION
Target $77
JPMS
Neutral
Colgate-Palmolive initiated with a Neutral at JPMorgan
JPMorgan analyst Andrea Teixeira started Colgate-Palmolive with a Neutral rating and $77 price target.
05/17/17
JEFF
05/17/17
NO CHANGE
JEFF
Jefferies sees Unilever as interested if Colgate is for sale
After the New York Post reported that Colgate (CL) may be willing to sell for $100 per share, Jefferies analyst Martin Deboo says he'd expect Unilever (UN, UL) to be an interested party. The analyst notes he's argued for some time that Unilever should create a "New World Order" in Household & Personal Care by acquiring Colgate. Such a deal would support his bullish thesis on Unilever shares.
04/10/17
DBAB
04/10/17
NO CHANGE
DBAB
Deutsche sees Personal Care stocks giving up recent gains
Deutsche Bank analyst Faiza Alwy expects stocks in the Cosmetics, Household and Personal Care space to give up their recent gains. The market seems to have decided that 3G or Unilever (UN, UL) is interested in acquiring U.S. HPC stocks with the group up 11% year-to-date, Alwy tells investors in a research note. The analyst sees M&A as unlikely in the near-term and points out that interest rates are rising. Alwy keeps Hold ratings on Colgate-Palmolive (CL), Clorox (CLX), Edgewell Personal Care (EPC) and Kimberly-Clark (KMB).
04/18/17
JEFF
04/18/17
INITIATION
Target $78
JEFF
Hold
Colgate-Palmolive initiated with a Hold at Jefferies
Jefferies analyst Kevin Grundy started Colgate-Palmolive with a Hold rating and $78 price target. The analyst views the sock as fully valued at current levels.

TODAY'S FREE FLY STORIES

WLKP

Westlake Chemical Partners

$24.00

0.05 (0.21%)

16:10
09/26/17
09/26
16:10
09/26/17
16:10
Syndicate
Westlake Chemical Partners files to sell 4.5M units for limited partners »

UBS Investment Bank,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLKP

Westlake Chemical Partners

$24.00

0.05 (0.21%)

16:09
09/26/17
09/26
16:09
09/26/17
16:09
Hot Stocks
Westlake Chemical Partners to acquire extra 5% interest in OpCo »

Westlake Chemical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNDC

Landec

$12.55

0.6 (5.02%)

16:08
09/26/17
09/26
16:08
09/26/17
16:08
Earnings
Landec reports Q1 EPS 8c, consensus 6c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

MU

Micron

$34.18

-0.69 (-1.98%)

16:08
09/26/17
09/26
16:08
09/26/17
16:08
Technical Analysis
Technical View: Micron spikes higher after earnings beat »

In the extended session…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

MU

Micron

$34.18

-0.69 (-1.98%)

16:07
09/26/17
09/26
16:07
09/26/17
16:07
Hot Stocks
Micron CEO expects healthy industry fundamentals to continue into 2018 »

"Micron delivered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AMSC

AMSC

$4.03

0.01 (0.25%)

16:06
09/26/17
09/26
16:06
09/26/17
16:06
Hot Stocks
AMSC completes acquisition of Infinia Technology »

AMSC announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

16:06
09/26/17
09/26
16:06
09/26/17
16:06
Hot Stocks
Micron says Q4 margin increase due to DRAM products »

Revenues for the fourth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

GFF

Griffon

$21.55

0.55 (2.62%)

, EMR

Emerson

$63.13

-0.48 (-0.75%)

16:06
09/26/17
09/26
16:06
09/26/17
16:06
Hot Stocks
Griffon amends ClosetMaid purchase agreement »

Griffon Corporation (GFF)…

GFF

Griffon

$21.55

0.55 (2.62%)

EMR

Emerson

$63.13

-0.48 (-0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

AVGR

Avinger

$0.21

-0.0211 (-9.13%)

16:04
09/26/17
09/26
16:04
09/26/17
16:04
Hot Stocks
Avinger receives CE Marking approval for in-stent restenosis treatment »

Avinger announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLBD

Blue Bird

$18.85

0.2 (1.07%)

16:03
09/26/17
09/26
16:03
09/26/17
16:03
Hot Stocks
Blue Bird enters stock repurchase agreement with Coliseum Capital »

Blue Bird Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

AMGN

Amgen

$185.60

-0.69 (-0.37%)

, SCR

Simcere

16:03
09/26/17
09/26
16:03
09/26/17
16:03
Hot Stocks
Amgen and Simcere execute agreement to co-develop four biosimilars in China »

Amgen (AMGN) and Simcere…

AMGN

Amgen

$185.60

-0.69 (-0.37%)

SCR

Simcere

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

ITCI

Intra-Cellular

16:02
09/26/17
09/26
16:02
09/26/17
16:02
Syndicate
Intra-Cellular files to sell $150M in common stock »

J. P. Morgan Securities…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

MU

Micron

16:01
09/26/17
09/26
16:01
09/26/17
16:01
Earnings
Micron reports Q4 EPS $2.02 , consensus $1.84 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

SIEGY

Siemens

$68.96

-0.81 (-1.16%)

, ALSMY

Alstom

$3.91

-0.045 (-1.14%)

15:58
09/26/17
09/26
15:58
09/26/17
15:58
Hot Stocks
Siemens, Alstom confirm agreement to combine mobility businesses »

Siemens (SIEGY) and…

SIEGY

Siemens

$68.96

-0.81 (-1.16%)

ALSMY

Alstom

$3.91

-0.045 (-1.14%)

GE

General Electric

$24.97

-0.145 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

HII

Huntington Ingalls

$222.73

2.25 (1.02%)

15:50
09/26/17
09/26
15:50
09/26/17
15:50
Hot Stocks
Huntington Ingalls partners with Ivis to develop compliance software »

Huntington Ingalls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JD

JD.com

$40.93

-1.44 (-3.40%)

15:50
09/26/17
09/26
15:50
09/26/17
15:50
Options
JD options volume is 2.5X daily average and calls outpace puts 4:1 »

JD options volume is 2.5X…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$171.00

-8 (-4.47%)

, INTC

Intel

$37.16

-0.02 (-0.05%)

15:42
09/26/17
09/26
15:42
09/26/17
15:42
Periodicals
Breaking Periodicals news story on Nvidia, Intel, Tesla »

Tesla shifting from…

NVDA

Nvidia

$171.00

-8 (-4.47%)

INTC

Intel

$37.16

-0.02 (-0.05%)

TSLA

Tesla

$344.99

-6.1 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 05

    Oct

  • 08

    Oct

  • 22

    Oct

AMZN

Amazon.com

$939.79

-15.31 (-1.60%)

, TWLO

Twilio

$28.86

-0.615 (-2.09%)

15:38
09/26/17
09/26
15:38
09/26/17
15:38
Hot Stocks
Amazon discussses launch of AWS Global SMS two-way text messaging »

Amazon's (AMZN)…

AMZN

Amazon.com

$939.79

-15.31 (-1.60%)

TWLO

Twilio

$28.86

-0.615 (-2.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 08

    Oct

  • 22

    Oct

LNDC

Landec

$11.95

-0.3 (-2.45%)

15:34
09/26/17
09/26
15:34
09/26/17
15:34
Options
Landec options imply 12.6% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

T

AT&T

$38.80

-0.32 (-0.82%)

15:30
09/26/17
09/26
15:30
09/26/17
15:30
Periodicals
AT&T's DirecTV to allow 'some' refunds after anthem strife, WSJ says »

Certain subscribers to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Nov

AMJ

American Medical Laboratories Inc

$28.50

0.01 (0.04%)

15:30
09/26/17
09/26
15:30
09/26/17
15:30
Options
Alerian MLP attracts a bullish option play »

Alerian MLP attracts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$85.47

-1.105 (-1.28%)

15:27
09/26/17
09/26
15:27
09/26/17
15:27
Hot Stocks
AbbVie says will take one single digit price increase for 2018 »

AbbVie issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 08

    Nov

STZ

Constellation Brands, also tag STZ.B

$200.37

-0.24 (-0.12%)

15:25
09/26/17
09/26
15:25
09/26/17
15:25
Options
Constellation Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Oct

$NSD

NASDAQ Market Internals

15:17
09/26/17
09/26
15:17
09/26/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
09/26/17
09/26
15:16
09/26/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.